Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801) - Image 1

£179.00

Springer Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)

Name: Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)
Brand: Springer
Price: 179.0 GBP
Availability: InStock

Optometry - Opticians

Price History & Forecast

Last 3 days • 3 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 3 days • 1 price levels

Days at Price

Price Analysis

Most common price: £179 (3 days, 100.0%)

Price range: £179 - £179

Price levels: 1 different prices over 3 days

Description

This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 1461432081
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Optometry - Opticians
Domain: Amazon UK
Release Date: 25 March 2014
Listed Since: 16 December 2011

Barcode

No barcode data available

Springer Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology, 801)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 801 (Advances in Experimental Medicine and Biology)

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1074 (Advances in Experimental Medicine and Biology, 1074)

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 1185 (Advances in Experimental Medicine and Biology, 1185)

Retinal Degenerative Diseases: Mechanisms and Experimental Therapy: 854 (Advances in Experimental Medicine and Biology, 854)

Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)

Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations: 664 (Advances in Experimental Medicine and Biology, 664)

Recent Advances In Retinal Degeneration: 613 (Advances in Experimental Medicine and Biology, 613)

Springer Age-related Macular Degeneration - Medical Textbook

Retinal Degenerations: Mechanisms and Experimental Therapy: 533 (Advances in Experimental Medicine and Biology, 533)

New Insights Into Retinal Degenerative Diseases

Cellular Therapies for Retinal Disease: A Strategic Approach

Molecular Mechanisms of Retina Pathology and Ways of its Correction

Neuroprotection and Neuroregeneration for Retinal Diseases

Studies on Retinal and Choroidal Disorders (Oxidative Stress in Applied Basic Research and Clinical Practice)

Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases: 35 (Topics in Medicinal Chemistry, 35)

Retinal Degenerative Diseases

Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases: 35 (Topics in Medicinal Chemistry, 35)

Stem Cell Research and Therapeutics: 1 (Advances in Biomedical Research, 1)

Retinal Degenerative Diseases: 572 (Advances in Experimental Medicine and Biology, 572)

Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies

Inherited Retinal Disease

Inherited Retinal Disease